TY - JOUR
T1 - Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement
AU - Yamabe, Sayuri
AU - Dohi, Yoshihiro
AU - Higashi, Akifumi
AU - Kinoshita, Hiroki
AU - Sada, Yoshiharu
AU - Hidaka, Takayuki
AU - Kurisu, Satoshi
AU - Shiode, Nobuo
AU - Kihara, Yasuki
AU - HERO (Hiroshima Heart Study Group) Investigators, (Hiroshima Heart Study Group) Investigators
N1 - Publisher Copyright:
© 2015, Springer Japan.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Electrocardiographic left ventricular hypertrophy (ECG-LVH) gradually regressed after aortic valve replacement (AVR) in patients with severe aortic stenosis. Sokolow–Lyon voltage (SV1 + RV5/6) is possibly the most widely used criterion for ECG-LVH. The aim of this study was to determine whether decrease in Sokolow–Lyon voltage reflects left ventricular reverse remodeling detected by echocardiography after AVR. Of 129 consecutive patients who underwent AVR for severe aortic stenosis, 38 patients with preoperative ECG-LVH, defined by SV1 + RV5/6 of ≥3.5 mV, were enrolled in this study. Electrocardiography and echocardiography were performed preoperatively and 1 year postoperatively. The patients were divided into ECG-LVH regression group (n = 19) and non-regression group (n = 19) according to the median value of the absolute regression in SV1 + RV5/6. Multivariate logistic regression analysis was performed to assess determinants of ECG-LVH regression among echocardiographic indices. ECG-LVH regression group showed significantly greater decrease in left ventricular mass index and left ventricular dimensions than Non-regression group. ECG-LVH regression was independently determined by decrease in the left ventricular mass index [odds ratio (OR) 1.28, 95 % confidence interval (CI) 1.03–1.69, p = 0.048], left ventricular end-diastolic dimension (OR 1.18, 95 % CI 1.03–1.41, p = 0.014), and left ventricular end-systolic dimension (OR 1.24, 95 % CI 1.06–1.52, p = 0.0047). ECG-LVH regression could be a marker of the effect of AVR on both reducing the left ventricular mass index and left ventricular dimensions. The effect of AVR on reverse remodeling can be estimated, at least in part, by regression of ECG-LVH.
AB - Electrocardiographic left ventricular hypertrophy (ECG-LVH) gradually regressed after aortic valve replacement (AVR) in patients with severe aortic stenosis. Sokolow–Lyon voltage (SV1 + RV5/6) is possibly the most widely used criterion for ECG-LVH. The aim of this study was to determine whether decrease in Sokolow–Lyon voltage reflects left ventricular reverse remodeling detected by echocardiography after AVR. Of 129 consecutive patients who underwent AVR for severe aortic stenosis, 38 patients with preoperative ECG-LVH, defined by SV1 + RV5/6 of ≥3.5 mV, were enrolled in this study. Electrocardiography and echocardiography were performed preoperatively and 1 year postoperatively. The patients were divided into ECG-LVH regression group (n = 19) and non-regression group (n = 19) according to the median value of the absolute regression in SV1 + RV5/6. Multivariate logistic regression analysis was performed to assess determinants of ECG-LVH regression among echocardiographic indices. ECG-LVH regression group showed significantly greater decrease in left ventricular mass index and left ventricular dimensions than Non-regression group. ECG-LVH regression was independently determined by decrease in the left ventricular mass index [odds ratio (OR) 1.28, 95 % confidence interval (CI) 1.03–1.69, p = 0.048], left ventricular end-diastolic dimension (OR 1.18, 95 % CI 1.03–1.41, p = 0.014), and left ventricular end-systolic dimension (OR 1.24, 95 % CI 1.06–1.52, p = 0.0047). ECG-LVH regression could be a marker of the effect of AVR on both reducing the left ventricular mass index and left ventricular dimensions. The effect of AVR on reverse remodeling can be estimated, at least in part, by regression of ECG-LVH.
UR - http://www.scopus.com/inward/record.url?scp=84946123152&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946123152&partnerID=8YFLogxK
U2 - 10.1007/s00380-015-0761-2
DO - 10.1007/s00380-015-0761-2
M3 - Article
C2 - 26531830
AN - SCOPUS:84946123152
SN - 0910-8327
VL - 31
SP - 1497
EP - 1503
JO - Heart and Vessels
JF - Heart and Vessels
IS - 9
ER -